Intraaortic balloon pump in myocardial infarction: Always, Never, or for the Right Patient?
Jeffrey M TylerTimothy D HenryPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
SEMPER FI was a 100-patient pilot study that randomized acute myocardial infarction (AMI) patients with persistent ischemia following percutaneous coronary intervention (PCI) to intraaortic balloon pump (IABP) versus control. AMI patients with persistent ischemia receiving short-term IABP post-PCI had a greater resolution of persistent ST segment elevation and a trend for decreased clinical events. These results support a larger adequately powered trial of IABP versus control in AMI patients with persistent ischemia following primary PCI.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- left ventricular
- st elevation myocardial infarction
- acute coronary syndrome
- coronary artery disease
- antiplatelet therapy
- coronary artery bypass grafting
- phase iii
- case report
- heart failure
- clinical trial
- phase ii
- atrial fibrillation
- coronary artery bypass
- double blind
- study protocol
- randomized controlled trial